A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia
Boston Children's Hospital · Dana-Farber Cancer Institute · +9 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
445
total citations
- FWCI
- 14.70
- Percentile
- 100%
- References
- 71
Citations per year
Authors
28- AVAndrei V. Krivtsov
Boston Children's Hospital, Dana-Farber Cancer Institute
- KEKathryn Evans
UNSW Sydney
- JYJayant Y. Gadrey
Boston Children's Hospital, Dana-Farber Cancer Institute
- BKBenjamin K. Eschle
Boston Children's Hospital, Dana-Farber Cancer Institute
- CHCharlie Hatton
Boston Children's Hospital, Dana-Farber Cancer Institute
Topics & keywords
Topics
Keywords
- Myeloid leukemia
- Chromatin
- Cancer research
- Leukemia
- Biology
- Myeloid
- Apoptosis
- Gene
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- UDU.S. Department of EnergyAward: DE-AC02-06CH11357
- AAstraZeneca
- NNovartis
- ATAnika Therapeutics
- IMIndustrial Macromolecular Crystallography Association Collaborative Access Team
- SPSyndax Pharmaceuticals
- CICancer Institute NSW
- NINational Institutes of Health
- NHNational Health and Medical Research CouncilAwards: APP1139787, APP1157871, APP1102589, APP1059804
- NCNational Cancer InstituteAwards: P01 CA066996, P50 CA206963, U01 CA199222, U01 CA199000, R01 CA204639, R01 CA176745
- JPJanssen Pharmaceuticals